Unbiased Analysis of Today's Healthcare Issues
That is the title of a paper currently published (well, in pre-prints) at Value in Health. Co-authors include Jaehong Kim, Moises Marin MA, Sangeetha Ramsagar, Mark Lloyd Davies, Kyana Stewart, Iftekhar Kalsekar and Anil Vachani. The abstract is below: ObjectiveTo measure the value of increasing lung cancer screening rates for high-risk individuals and its impact…
That is the title of my new paper published today in Clinical and Applied Thrombosis/Hemostasis with co-authors Denise Clayton, Glorian Yen, Soyon Lee, Lincy Geevarghese, Yulin Shi, Luyang He, Ying Shen, and Anem Waheed. The abstract is below: Paroxysmal nocturnal hemoglobinuria (PNH) is a rare, acquired hematologic disorder commonly treated with complement inhibitors such as…
That is the title of my new paper out in ClinicoEconomics and Outcomes Research. This work was done with co-authors Kyi-Sin Than, Anmol Kanotra, Kirk W Kerr, Katie N Robinson, Michael C Willey. The abstract is below. Objective: To measure the economic impact of conditionally essential amino acids (CEAA) among patients with operative treatment for fractures.Methods: A…
That is the title of a study presented this week at the Obesity Week conference. This is work used a distributional cost effectiveness analysis approach for measuring the value of semaglutide 2.4 mg for the treatment of patients with obesity and overweight. It was conducted with co-authors Joshua Toliver, Mads Faurby, Jaehong Kim, Sanjana Muthukrishnan…
My paper with co-authors Shanshan Wang and Kirk Kirr just came out in the Journal of Long-Term Care titled Wound-Specific Oral Nutritional Supplementation Can Reduce the Economic Burden of Pressure Injuries for Nursing Homes: Results from an Economic Model. The abstract is below. Background To measure the cost savings and staff time savings of wound-specific…
That is the title of a study published today with co-authors Sabiha Quddus, Moises Marin, and Dennis Scanlon PhD. The abstract is below. ObjectiveTo estimate the incremental health benefits of pharmaceutical innovations approved between 2011-2021 and the share that would surpass the National Institute for Health and Care Excellence (NICE) ‘size of benefit’ decision weight…
That is the title of a new working paper written by myself, any my FTI Consulting colleagues Sabiha Quddus and Suhail Thahir. The abstract is below. Some policymakers have called for weakening of intellectual property protections for vaccines and other pharmaceutical products, with the aim to reduce the price and improve access to existing medical…
If you’re attending the ISPOR 2023 conference in Boston, MA please feel free to come by view some of my research. This includes the following: Podium Presentation #108: Economic Evaluations of Rare Diseases: “Quantifying the Insurance and Altruism Value for Rare Diseases: A Case Study for Duchenne Muscular Dystrophy”. Jason Shafrin will be presenting this work as…
This is the title of my Health Affairs Forefront article published today alongside co-authors Darius Lakdawalla, Jalpa Doshi, Louis Garrison, Anup Malani, Peter Neumann, Charles Phelps, Adrian Towse, and Richard Willke. The article begins by discussing some of the pros and cons of different approaches for CMS to set the maximum fair price (MFP). Across…
I just reached 1000 citations for my research in Google Scholar. Very exciting! To read my research, click here.